Evidence map›Paper›PMID 32839875›Full record

ArticleMikrochimica acta2020

A label-free reusable aptasensor for Alzheimer's disease.

Hong-Xia Ren, Qilong Zhong, Yang-Bao Miao, Xiao-Wei Wen, Gui-Yan Wu, Hui-Ling Wang, Ying Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Biomedical Applications of Metal-Organic Frameworks Revisited.Industrial & engineering chemistry research · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hong-Xia RenSchool of Chemistry and Chemical Engineering, Zunyi Normal College, Zunyi, 563000, Guizhou, China. renhongxiahappy@126.com.
Qilong ZhongNingbo No. 7 Hospital, Ningbo, 510530, China.
Yang-Bao MiaoDepartment of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan, 30013.
Xiao-Wei WenSchool of Chemistry and Chemical Engineering, Zunyi Normal College, Zunyi, 563000, Guizhou, China.
Gui-Yan WuSchool of Chemistry and Chemical Engineering, Zunyi Normal College, Zunyi, 563000, Guizhou, China.
Hui-Ling WangSchool of Chemistry and Chemical Engineering, Zunyi Normal College, Zunyi, 563000, Guizhou, China.
Ying ZhangSchool of Chemistry and Chemical Engineering, Zunyi Normal College, Zunyi, 563000, Guizhou, China.
Zunyi Normal College · CNNational Tsing Hua University · TWNingbo No.6 Hospital · CN

Funding

2018 Academic New Seedling Cultivation and Innovation Exploration Project of Guizhou Provincial Science and Technology Department [2018]5784-05Ph. D. Foundation of Zunyi Normal College BS[2019]10
6 · The paper itself

Abstract

To early effectively detect amyloid-beta (Aβ) oligomers, a label-free reusable aptasensor was designed. This aptasensor based on a luminescent nanoscale lanthanum-based metal-organic framework (L-MOF)-armored single-stranded DNA antibody (MOF-armored-anti-DNA antibody) as signal tags and aptamer bound to magnetic beads (Apt-MB) as capture probe. The reusable aptasensor combines signal tag and capture probe with antigen-antibody interaction. When the reusable aptasensor is formed, the strong fluorescence intensity of L-MOF will "turn off" by photo-induced electron transfer from excited states to an unfilled d shell of iron cations on the nanoparticle surface. Upon the presence of Aβ oligomers in serum samples, they can be especially distinguished with the Aβ oligomers aptamer in capture probes and then signal tags are released into the solution for developing the fluorescence aptasensor under excitation/emission 365 nm/430 nm. Meanwhile, the aptamer was recovered from the complex of Aβ oligomers/Apt-MB by heat treatment. When the temperature returns to room temperature, the recovered aptamer in the capture probe can once again bound to the MOF-armored-anti-DNA antibody for reuse. The label-free reusable aptasensor system detection has high sensitivity and selectivity toward Aβ oligomers (LOD = 0.4 pg/mL) and an excellent linear range (0.001-100 ng/mL). This strategy is a fruitful step for the development of reusable aptasensor and may turn on new avenues for the applications of Aβ oligomer detection in clinical diagnosis.Graphical abstract.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAntibodies, ImmobilizedAptamers, NucleotideBiosensing TechniquesDNA, Single-StrandedFluorescent DyesHumansImmunomagnetic SeparationLanthanumLimit of DetectionMagnetite NanoparticlesMetal-Organic FrameworksProtein Structure, QuaternarySpectrometry, FluorescenceAmyloid beta-PeptidesAntibodies, ImmobilizedAptamers, NucleotideDNA, Single-StrandedFluorescent DyesLanthanumMagnetite NanoparticlesMetal-Organic FrameworksLabel-free strategyLuminescence MOFReusable aptasensorTurn-on strategyVisualization Alzheimer’s disease

Identifiers

PMID32839875
OpenAlexW3080415384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.